Intended for US
CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
So you and your doctor can create a treatment plan based on your administration preferences.
Faster infusions1
In the study,* once-weekly infusions took just under an hour.†
Fewer needlesticks1
In the study,* most (84.9%) used 1 to 2 needlesticks.
Flexible schedule1
CUVITRU can be infused at the fastest rates of any subQ (up to 60mL/hr/site as tolerated)‡. With the fastest rates of any SCIG, CUVITRU makes treatment every 1 to 2 weeks a reality even for patients with the highest volumes.
*The average infusion time was 0.95 (range 0.2-6.4 hours).
†CUVITRU was studied in 77 people with primary immunodeficiency (PI) ≥2 years of age, with the main goal of measuring how many acute serious bacterial infections (ASBIs) were experienced over the course of 1 year. ASBIs are short-term but serious infections that require immediate medical care.
‡You'll infuse your first 2 infusions at 10 to 20 mL/hr/site. After that, you'll be able to increase your rate, as tolerated. You’ll infuse your first 2 infusions at 10 to 20 mL/hr/site. After that, you'll be able to increase your rate, as tolerated. Infuse at up to 4 sites simultaneously.
It's important to understand that CUVITRU is not right for everyone. It can cause severe allergic reactions, skin rashes and other side effects. Talk to your doctor about any concerns you may have before starting CUVITRU or at any time during your treatment with CUVITRU.
If you’d like help making sure you’re having a helpful conversation with your doctor, fill out our discussion guide and take it to your appointment with you.
Get the guide
Your healthcare team will teach you how to administer CUVITRU step-by-step, so you can infuse at home.1
See how others are creating treatment plans to meet their needs.
Read patient stories